Australians are facing a shortage of critical medicines, including essential drugs for surgery and rare conditions, the federal government’s Therapeutic Goods Administration has warned.
There is currently a shortage of 41 critical medications.
Overall, there is a shortage of more than 400 medications — with more than 60 anticipated to go into shortage and more than 250 discontinued.
Watch the latest news and stream for free on 7plus >>
Critical medicines in shortage include Suxamethonium Juno, which is used to relax muscles moving during surgery or medical procedures.
New supplies of the medicine are not expected until May next year.
DBL Sodium Thiosulfate Injection — which is used to treat cyanide poisoning — is also on the list with new stock not expected until April next year.
Medicines for cancer treatment, including Ethyol Amifostine, which is used to prevent kidney damage from chemotherapy, are also in shortage.
Antidepressants and antibiotics are also on the list of critical shortages, with dates of new supply ranging from this month well into next year.
Medicines on the list of non-critical shortages include those used to treat schizophrenia, Parkinson’s disease, arthritis, type 2 diabetes and more.
Most medicines have expected resupply dates in December or January, though it may be months before others are restocked.
Patients who require critical medicines will be provided alternative unapproved products available under the Special Access Scheme.
You can view the full list of shortages on the Therapeutic Goods Association (TGA) website, as well as the list of critical shortages.